The US pain management market growth is charting an impressive trajectory as the convergence of genomics, pharmacogenomics, and personalized medicine creates novel opportunities for genetically guided pain therapy that optimizes analgesic selection and dosing while minimizing adverse effects. Pharmacogenomic testing enables prediction of opioid metabolism rates, non-steroidal anti-inflammatory...